Celyad SA | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (14)

Latest Posts

About This Stock More About This Stock
Stocks Eye Daily, Weekly Drops As Omicron Variant Spreads
Article By: Schaeffers Research
Friday, December 3, 2021 12:34 PM EDT
This morning's rally was short-lived. The major indexes are headed toward both daily and weekly losses at midday.
In this article: UPST, QQQ, SPX, VIX, DJI, CYAD, DIDI
Read
Morning Call For Wednesday, May 16
Article By: Jim Van Meerten
Wednesday, May 16, 2018 7:54 AM EDT
Jun E-mini S&Ps (ESM18 +0.07%) this morning are up +0.07% as T-note yields stabilize.
In this article: ABR, MON, BMRN, BOOT, PSEC, MU, TEVA, TRIP, VSTM, OLLI, GEMP, CYAD, PETQ
Read
Novartis Grabs Licenses On New Tech For Next-Gen Therapies For CAR-T
Article By: Lorimer Wilson
Tuesday, May 2, 2017 3:30 PM EDT
The Belgian biotech Celyad announced that Novartis had gained non-exclusive rights to IP it has on allogeneic CAR-Ts, off-the-shelf cell therapies for cancer that could eventually prove superior to the autologous programs now lining up for approval.
In this article: CYAD, GSK, NVS, BLUE
Read

Latest Tweets for $CYAD

No tweets yet!

PARTNER HEADLINES